Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Watermelon shows promise for lowering blood pressure in Pre-Hypertension

NCT ID NCT05892328

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This completed pilot study tested whether eating watermelon can lower blood pressure in adults with pre-hypertension. 39 healthy overweight adults ate either 1 cup, 2 cups of watermelon, or a control (Italian ice) daily for 4 weeks. Researchers measured 24-hour blood pressure and other heart health markers to see if watermelon has a dose-dependent effect.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
watermelon flesh
What this could lead to
If it works, this could point toward a simple dietary approach to help manage pre-hypertension and reduce cardiovascular risk.
What could go wrong
This is a small pilot study with only 39 participants, so results may not apply widely. The effect on blood pressure may be small or not clinically meaningful.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

39 people

The number who actually took part.

Started

Apr 2023

Finished

Sep 2025

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

25 to 65 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Individuals who are nonsmokers * Healthy overweight/ obese man or woman between 25 and 65 years of age * Blood pressure 120-160 mmHg systolic or 80-100 mm/Hg diastolic at screening visit * Fasting blood glucose concentration between 100 mg/dL and 125 mg/dL at screening visit (value range indicate prediabetes, by finger prick and/or venous blood sampling) * Have no clinical evidence/history of cardiovascular, metabolic, respiratory, renal, gastrointestinal, or hepatic disease Exclusion Criteria: * Smoker * Vegetarian * Men and women who have fasting blood glucose concentration \<100 or \>125 mg/dL at screening visit * Uncontrolled blood pressure ≥140 mmHg (systolic)/ ≥ 90 mmHg (diastolic) * Over the counter supplements (e.g. fiber supplements, probiotics and/or prebiotics, antioxidants, anti-inflammation) * Dietary supplements like (garlic, fish oil), glutamine supplements, grape seed extract, L-citrulline/arginine * Cholesterol-lowering medications, anticoagulants, blood pressure-lowering medications,) and/or taking prescription medications that may interfere with study procedures or endpoints (e.g. gastrointestinal medications, antibiotics) within the last 30 days * Have cancer other than non-melanoma skin cancer in previous 5 years * Taking unstable dose of hormonal contraceptive and/or a stable dose less than 6 months * Planning to become pregnant, pregnant and/or breast-feeding * Excessive exerciser or a trained athlete * Drink excessive amount of coffee/tea (\> 5 cups per day) * Donated blood within last 3 months * Have allergies/intolerances to foods consumed in the study * Currently eat \> 2 servings of watermelons per day * Actively losing weight/ trying to lose weight (unstable body weight fluctuations of \> 11 lbs in 3 months) * Addicted to drugs or alcohol * Have significant psychiatric or neurological disturbances that may interfere with the ability to follow the study protocol

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cardiovascular diseases are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Clinical Nutrition Research Center

    Chicago, Illinois, 60616, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.